Clinical Trials Browser

Completed × Advanced Triple-Negative Breast Cancer × apatinib × Clear all

NCT03254654 2022-04-20

Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer

Phase 2 Completed

Advanced Triple-Negative Breast Cancer